rs387906758
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The ENST00000361099.8(STAT1):c.820C>T(p.Arg274Trp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R274G) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000361099.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STAT1 | NM_007315.4 | c.820C>T | p.Arg274Trp | missense_variant | 10/25 | ENST00000361099.8 | NP_009330.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STAT1 | ENST00000361099.8 | c.820C>T | p.Arg274Trp | missense_variant | 10/25 | 1 | NM_007315.4 | ENSP00000354394 | P4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2011 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.85; 3Cnet: 0.99). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000030083). The variant has been previously reported as de novo in at least one similarly affected unrelated individual (3billion dataset). and to co-segregate with the disease in multiple similarly affected individuals from unrelated families (PMID:21727188). Different missense changes at the same codon (p.Arg274Gln, p.Arg274Gly) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000030085, VCV000160354). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, criteria provided, single submitter | clinical testing | UCLA Clinical Genomics Center, UCLA | Aug 21, 2012 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Jul 31, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2018 | - - |
STAT1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 24, 2023 | The STAT1 c.820C>T variant is predicted to result in the amino acid substitution p.Arg274Trp. This variant has been reported in the heterozygous state in individuals with chronic mucocutaneous candidiasis and immunodeficiency (Tables S9 and S10, van de Veerdonk et al. 2011. PubMed ID: 21714643; Depner et al. 2016. PubMed ID: 26604104; Patient S103, Baxter et al. 2021. PubMed ID: 33864888). Of note, this variant segregated with disease in one family, being present in three affected family members and was not identified in nine unaffected individuals (Tables S9 and S10, van de Veerdonk et al. 2011. PubMed ID: 21714643). Of note, other variants impacting p.Arg274 have also been reported in individuals with mucocutaneous candidiasis or disseminated histoplasmosis (p.Arg274Gly and p.Arg274Gln; Liu. 2011. PubMed ID: 21727188; Patient 5, Sampaio et al. 2013. PubMed ID: 23541320; Depner et al. 2016. PubMed ID: 26604104). Of note, all of these variants impacting p.Arg274 have been reported to be gain-of-function variants. This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare, and is reported as pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/30083/). This variant is interpreted as pathogenic. - |
Immunodeficiency 31B;C3279990:Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome;C4013950:Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 274 of the STAT1 protein (p.Arg274Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with chronic mucocutaneous candidiasis (PMID: 21714643, 21727188, 25326637, 25367169, 26604104). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 30083). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects STAT1 function (PMID: 21714643, 22195034, 26255980). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at